Scientific Reference

Wolverine Stack (BPC-157 + TB-500)

Evidence profile: Component evidence only — this formulation has not itself been studied

The Wolverine Stack is a two-peptide regenerative combination consisting of BPC-157 and TB-500 (Thymosin Beta-4). It is one of the most widely studied peptide pairings for tissue repair, combining localised and systemic healing mechanisms.\n\nTypical formulations include approximately 10mg BPC-157 and 10mg TB-500. While both peptides have established preclinical research backgrounds, no clinical trials have evaluated this specific combination, and all effects remain theoretical.

Mechanism of Action

The Wolverine Stack combines two complementary mechanisms: BPC-157 promotes localised repair via nitric oxide modulation and growth factor signalling, while TB-500 enhances systemic repair through actin regulation and cellular migration. Together, these pathways aim to support coordinated tissue healing and regeneration.

Molecular Information

  • Type: Multi-peptide protocol

Published Research

  • Thymosin beta 4: A potential novel adjunct treatment for bacterial keratitis

    Sosne G et al. · International immunopharmacology · 2023 · Clinical · Evidence for TB-500 (Thymosin Beta-4)

    PMID 37018981 — View on PubMed
  • RGN-259 neurotrophic keratopathy phase III

    0.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical Trial

    Sosne G et al. · International journal of molecular sciences · 2022 · Clinical · Evidence for TB-500 (Thymosin Beta-4)

    PMID 36613994 — View on PubMed
  • The effect of thymosin treatment of venous ulcers

    Guarnera G et al. · Annals of the New York Academy of Sciences · 2010 · Clinical · Evidence for TB-500 (Thymosin Beta-4)

    PMID 20536470 — View on PubMed
  • A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers

    Ruff D et al. · Annals of the New York Academy of Sciences · 2010 · Clinical · Evidence for TB-500 (Thymosin Beta-4)

    PMID 20536472 — View on PubMed
  • Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians

    Mayfield CK et al. · The American journal of sports medicine · 2026 · Review · Evidence for BPC-157

    PMID 41476424 — View on PubMed
  • From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management

    Yuan C et al. · International journal of molecular sciences · 2026 · Review · Evidence for BPC-157

    PMID 41898733 — View on PubMed